CIK 0002131524 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Braveheart Bio, Inc.
Sign in to watch- Ticker
- BRVE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 992981994
- Phone
- (415) 707-6312
- Business address
- ONE LETTERMAN DR., BLDG. A, STE. A4-300, SAN FRANCISCO, CA, 94129
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-07 | Forbion Growth Opportunities Fund III Cooperatief U.A. 10% owner | Conversion | +7,990,867 | 8,505,478 | ||
| 2026-08-07 | Forbion Growth Opportunities Fund III Cooperatief U.A. 10% owner | Purchase | +1,920,000 | $18.00 | $34.6M | 11,640,546 |
| 2026-08-07 | Forbion Growth Opportunities Fund III Cooperatief U.A. 10% owner | Purchase | +1,680,000 | $18.00 | $30.2M | 10,185,478 |
| 2026-08-07 | Forbion Growth Opportunities Fund III Cooperatief U.A. 10% owner | Conversion · Series A Preferred Stock | −40,000,000 | 0 | ||
| 2026-08-07 | Forbion Growth Opportunities Fund III Cooperatief U.A. 10% owner | Conversion · Series A Preferred Stock | −35,000,000 | 0 | ||
| 2026-08-05 | Rickey James Paul Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2026-08-05 | Lohoff Tim Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2026-08-05 | Chimovits Erez Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2026-08-05 | Viehbacher Christopher Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2026-08-05 | Malek David I Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2026-08-05 | Anderson Michele A. Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2026-08-05 | Murdoch Travis CEO and President | Grant or award · Stock Option (Right to Buy) | +550,000 | 550,000 | ||
| 2026-08-05 | Bos Jasper Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2026-08-05 | Lubner David Charles Director | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 |
Page 2 of 2 · 34 trades